Eligibility


Eligible countries are defined in a series of schedules that can be accessed directly through the CAMR website:

http://camr-rcam.hc-sc.gc.ca/intro/index_e.html

Instructions vary slightly depending on a country’s World Trade Organization (WTO) status however, most countries with ‘Least Developed Nation’ status under the United Nations classification will be contained in these schedules.

Please refer to the schedules to identify the appropriate steps for each country.
In principle, the CAMR requires that eligible countries first make a formal request to the TRIPS Council of the WTO. They must state the need for the specific product, that there is not sufficient local manufacturing capacity to make the product in their country. Also that the government intends to issue a compulsory license for the product should patents be in force during the timeframe of the request. The specific steps for the process as well as draft letters can be found on the CAMR website at:

http://camr-rcam.hc-sc.gc.ca/countr-pays/proc-formal/notif_wto-avis_omc_e.html

Copies of all letters sent to the TRIPS Council should be forwarded to Apotex to the attention of: Bruce Clark, so that they can be included in our formal application to the Canadian Government. In addition, an email notification to Apotex should be made to ensure that we are advised of the request.

Please send the email to: apo-triavir@apotex.com